{"id":2761,"date":"2020-09-22T07:30:53","date_gmt":"2020-09-22T11:30:53","guid":{"rendered":"https:\/\/bridgebioprod.wpengine.com\/?p=2761"},"modified":"2022-06-23T11:42:44","modified_gmt":"2022-06-23T15:42:44","slug":"bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020","status":"publish","type":"post","link":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020\/","title":{"rendered":"BridgeBio Pharma to Host Virtual R&#038;D Day on September 29, 2020"},"content":{"rendered":"\r\n<p>Palo Alto, Calif. Sept. 22, 2020 \u2013 BridgeBio Pharma, Inc. (Nasdaq: BBIO), a clinical-stage biopharmaceutical company focused on genetic diseases and cancers with clear genetic drivers, today announced that it will host its first R&amp;D Day on Tuesday, September 29, at 8:30 am E.T.<\/p>\r\n\r\n\r\n\r\n<p>The virtual event will feature presentations from BridgeBio founder and CEO, Neil Kumar, Ph.D., senior scientists and physicians leading BridgeBio&#8217;s drug discovery and development programs, and top academic physicians and scientists from outside the company.<\/p>\r\n\r\n\r\n\r\n<p>The program will focus on BridgeBio\u2019s drug engineering platform, its targeted oncology portfolio, and four highlighted programs with clinical data anticipated in the next 12-24 months \u2013 acoramidis (AG10, TTR stabilizer) for transthyretin amyloidosis, low-dose infigratinib (FGFR inhibitor) for achondroplasia, AAV5 gene therapy for congenital adrenal hyperplasia, and encaleret (calcium sensing receptor antagonist) for autosomal dominant hypocalcemia type 1.<\/p>\r\n\r\n\r\n\r\n<p>Agenda:<br \/><strong>Welcome and introduction<\/strong> &#8211; Dr. Neil Kumar, Ph.D., CEO and founder of BridgeBio<br \/><strong>Program Spotlight &#8211; Achondroplasia<\/strong>: Dr. Ravi Savarirayan, M.D., Ph.D., Murdoch Children\u2019s Research Institute<br \/><strong>Program Spotlight &#8211; Transthyretin (TTR) Amyloidosis<\/strong>: Professor Julian D. Gillmore, M.D., Ph.D., Head, Centre for Amyloidosis &amp; Acute Phase Proteins, University College London<br \/><strong>Program Spotlight &#8211; Congenital Adrenal Hyperplasia (CAH)<\/strong>: Dr. Kyriakie Sarafoglou, M.D., Associate Professor, University of Minnesota Medical School and College of Pharmacy<br \/><strong>Program Spotlight &#8211; Autosomal Dominant Hypocalcemia Type 1 (ADH1)<\/strong>: Dr. Michael Collins, M.D., Chief of the Skeletal Disorders and Mineral Homeostasis Section, National Institutes of Health<br \/><strong>Program Spotlight -Targeted Oncology<\/strong>: Frank McCormick, Ph.D., BridgeBio Chairman of Oncology; Professor, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco<br \/><strong>Q&amp;A with attendees<\/strong><br \/><strong>Conclusion<\/strong> \u2013 Dr. Kumar<\/p>\r\n\r\n\r\n\r\n<p>The event will be webcast, with a link available in the event calendar on BridgeBio\u2019s investor website,\u00a0<a href=\"https:\/\/investor.bridgebiodev.wpengine.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/investor.bridgebiodev.wpengine.com\/<\/a>. A replay of the webcast will be available for one year following the event.<\/p>\r\n\r\n\r\n\r\n<p>To register for BridgeBio\u2019s R&amp;D Day, please sign up <a href=\"https:\/\/onlinexperiences.com\/scripts\/Server.nxp?LASCmd=AI:4;F:QS!10100&amp;ShowUUID=BE026B2A-E821-44EF-9744-3C166BA07B4A\" target=\"_blank\" rel=\"noreferrer noopener\">here.<\/a> To view the agenda and speaker profiles visit our R&amp;D Day <a href=\"https:\/\/bridgebiordday.splashthat.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">webpage<\/a>.<\/p>\r\n\r\n\r\n\r\n<p>US\/CANADA Participant Toll-Free Dial-In Number: (800) 379-2666<br \/>US\/CANADA Participant International Dial-In Number: (409) 937-8964<br \/>Conference ID: 6166916<\/p>\r\n\r\n\r\n\r\n<p>Attendees must register and watch the webcast to participate in the Q&amp;A sessions.<\/p>\r\n\r\n\r\n\r\n<p><strong>About BridgeBio Pharma, Inc.<\/strong><\/p>\r\n\r\n\r\n\r\n<p><a href=\"http:\/\/bridgebio.com\/\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>BridgeBio<\/strong><\/a>\u00a0is a team of experienced drug discoverers, developers and innovators working to create life-altering medicines that target well-characterized genetic diseases at their source. BridgeBio was founded in 2015 to identify and advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. BridgeBio\u2019s pipeline of over 20 development programs includes product candidates ranging from early discovery to late-stage development. For more information visit\u00a0<a href=\"http:\/\/bridgebio.com\/\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>bridgebiodev.wpengine.com<\/strong><\/a><\/p>\r\n\r\n\r\n\r\n<p><strong>Contact:<\/strong><br \/>Grace Rauh<br \/>BridgeBio Pharma, Inc.<br \/>Grace.rauh@bridgebiodev.wpengine.com<br \/>(917) 232-5478<\/p>\r\n\r\n\r\n\r\n<p>Source: BridgeBio Pharma, Inc.<\/p>\r\n","protected":false},"excerpt":{"rendered":"<p>Palo Alto, Calif. Sept. 22, 2020 \u2013 BridgeBio Pharma, Inc. (Nasdaq: BBIO), a clinical-stage biopharmaceutical company focused on genetic diseases and cancers with clear genetic drivers, today announced that it will host its first R&amp;D Day on Tuesday, September 29, at 8:30 am E.T. The virtual event will feature presentations from BridgeBio founder and CEO, [&hellip;]<\/p>\n","protected":false},"author":16,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[10],"tags":[],"class_list":["post-2761","post","type-post","status-publish","format-standard","hentry","category-press-release"],"acf":{"external_link":"","presentation":"","meta_short_title":"BridgeBio to Host Virtual R&D Day on September 29, 2020","meta_description":"","meta_share_image":false,"people":false},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Virtual R&amp;D Day | September 29, 2020 | BridgeBio<\/title>\n<meta name=\"description\" content=\"BridgeBio announced that it will host its first R&amp;D Day on Tuesday, September 29, at 8:30 am E.T. Learn all about the event today!\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Virtual R&amp;D Day | September 29, 2020 | BridgeBio\" \/>\n<meta property=\"og:description\" content=\"BridgeBio announced that it will host its first R&amp;D Day on Tuesday, September 29, at 8:30 am E.T. Learn all about the event today!\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020\/\" \/>\n<meta property=\"og:site_name\" content=\"BridgeBio\" \/>\n<meta property=\"article:published_time\" content=\"2020-09-22T11:30:53+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-06-23T15:42:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bridgebio.com\/wp-content\/uploads\/2019\/02\/BridgeBio_Share.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Cybele Gouverneur\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@BridgeBioPharma\" \/>\n<meta name=\"twitter:site\" content=\"@BridgeBioPharma\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Cybele Gouverneur\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020\/\",\"url\":\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020\/\",\"name\":\"Virtual R&D Day | September 29, 2020 | BridgeBio\",\"isPartOf\":{\"@id\":\"https:\/\/bridgebio.com\/#website\"},\"datePublished\":\"2020-09-22T11:30:53+00:00\",\"dateModified\":\"2022-06-23T15:42:44+00:00\",\"author\":{\"@id\":\"https:\/\/bridgebio.com\/#\/schema\/person\/0ccd4f21aad52916b60d0206bb498df7\"},\"description\":\"BridgeBio announced that it will host its first R&D Day on Tuesday, September 29, at 8:30 am E.T. Learn all about the event today!\",\"breadcrumb\":{\"@id\":\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/bridgebio.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BridgeBio Pharma to Host Virtual R&#038;D Day on September 29, 2020\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/bridgebio.com\/#website\",\"url\":\"https:\/\/bridgebio.com\/\",\"name\":\"BridgeBio\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/bridgebio.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/bridgebio.com\/#\/schema\/person\/0ccd4f21aad52916b60d0206bb498df7\",\"name\":\"Cybele Gouverneur\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/bridgebio.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1310df87abb2898678c7deb92afe7bc4?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1310df87abb2898678c7deb92afe7bc4?s=96&d=mm&r=g\",\"caption\":\"Cybele Gouverneur\"},\"url\":\"https:\/\/bridgebio.com\/author\/cybele-gouverneur\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Virtual R&D Day | September 29, 2020 | BridgeBio","description":"BridgeBio announced that it will host its first R&D Day on Tuesday, September 29, at 8:30 am E.T. Learn all about the event today!","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020\/","og_locale":"en_US","og_type":"article","og_title":"Virtual R&D Day | September 29, 2020 | BridgeBio","og_description":"BridgeBio announced that it will host its first R&D Day on Tuesday, September 29, at 8:30 am E.T. Learn all about the event today!","og_url":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020\/","og_site_name":"BridgeBio","article_published_time":"2020-09-22T11:30:53+00:00","article_modified_time":"2022-06-23T15:42:44+00:00","og_image":[{"width":1200,"height":600,"url":"https:\/\/bridgebio.com\/wp-content\/uploads\/2019\/02\/BridgeBio_Share.png","type":"image\/png"}],"author":"Cybele Gouverneur","twitter_card":"summary_large_image","twitter_creator":"@BridgeBioPharma","twitter_site":"@BridgeBioPharma","twitter_misc":{"Written by":"Cybele Gouverneur","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020\/","url":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020\/","name":"Virtual R&D Day | September 29, 2020 | BridgeBio","isPartOf":{"@id":"https:\/\/bridgebio.com\/#website"},"datePublished":"2020-09-22T11:30:53+00:00","dateModified":"2022-06-23T15:42:44+00:00","author":{"@id":"https:\/\/bridgebio.com\/#\/schema\/person\/0ccd4f21aad52916b60d0206bb498df7"},"description":"BridgeBio announced that it will host its first R&D Day on Tuesday, September 29, at 8:30 am E.T. Learn all about the event today!","breadcrumb":{"@id":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bridgebio.com\/"},{"@type":"ListItem","position":2,"name":"BridgeBio Pharma to Host Virtual R&#038;D Day on September 29, 2020"}]},{"@type":"WebSite","@id":"https:\/\/bridgebio.com\/#website","url":"https:\/\/bridgebio.com\/","name":"BridgeBio","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/bridgebio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/bridgebio.com\/#\/schema\/person\/0ccd4f21aad52916b60d0206bb498df7","name":"Cybele Gouverneur","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/bridgebio.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1310df87abb2898678c7deb92afe7bc4?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1310df87abb2898678c7deb92afe7bc4?s=96&d=mm&r=g","caption":"Cybele Gouverneur"},"url":"https:\/\/bridgebio.com\/author\/cybele-gouverneur\/"}]}},"_links":{"self":[{"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/posts\/2761"}],"collection":[{"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/comments?post=2761"}],"version-history":[{"count":0,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/posts\/2761\/revisions"}],"wp:attachment":[{"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/media?parent=2761"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/categories?post=2761"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/tags?post=2761"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}